2014
DOI: 10.3109/08977194.2014.969420
|View full text |Cite
|
Sign up to set email alerts
|

Roles of FGF-2 and TGF-beta/FGF-2 on differentiation of human mesenchymal stem cells towards nucleus pulposus-like phenotype

Abstract: Human mesenchymal stem cells (MSCs) are reported to have the capability of differentiating towards nucleus pulposus (NP)-like phenotype under specific culture conditions. So far, the effects of fibroblast growth factor (FGF)-2 and the cocktail effects of transforming growth factor (TGF)-beta and FGF-2 on MSCs remain unclear. Therefore, we designed this study to clarify these effects. MSCs were cultured in conditioned medium containing FGF-2 or TGF-beta/FGF-2, and compared with basal or TGF-beta medium. The gro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 40 publications
1
10
0
Order By: Relevance
“…In relation to chondrogenic differentiation markers, some authors have described the expression of COL2A1 and aggrecan in human adult MSCs differentiated in pellet culture [46]. Our assessment of these markers by Western blot revealed the expression of both proteins in spheroids cultured under normoxia and hypoxia, but greater chondrogenic differentiation was observed in the case of chondrospheroids cultured under hypoxia.…”
Section: Discussionmentioning
confidence: 66%
“…In relation to chondrogenic differentiation markers, some authors have described the expression of COL2A1 and aggrecan in human adult MSCs differentiated in pellet culture [46]. Our assessment of these markers by Western blot revealed the expression of both proteins in spheroids cultured under normoxia and hypoxia, but greater chondrogenic differentiation was observed in the case of chondrospheroids cultured under hypoxia.…”
Section: Discussionmentioning
confidence: 66%
“…For osteogenic differentiation (5154), MSC cultures were expanded by treatment with osteogenic induction medium (low‐sugar DMEM supplemented with 10% FBS, 100 nM dexamethasone, 0.2 μM ascorbic acid, and 10 mM β‐glycerophosphate). Cells were maintained by the addition of fresh osteogenic induction medium every 2‐3 d. For chondrogenic differentiation (55), cells were cultured in chondrogenic induction medium [high‐glucose DMEM, 40 μg/ml proline, 100 nM dexamethasone, 50 ng/ml ascorbic acid‐2‐phosphate, ITS‐X (insulin, transferrin, selenium, ethanolamine solution), and 10 ng/ml TGF ‐β 3] for 21 d. Sulfated glycosaminoglycans were stained with Alcian Blue (Cyagen Biosciences, Guangzhou, China).…”
Section: Methodsmentioning
confidence: 99%
“…Mesenchymal stem cell (MSC)-based tissue engineering treatment has been widely contemplated for the repair of IVD degeneration and has shown promising perspectives 108,109 . Studies show that TGF-b plays a vital role in it 110,111 . On one hand, TGF-b can synergize with other growth factors to promote the differentiation of MSCs towards NP-like cells, which supplies the quantity of IVD cells for the repair of IVD degeneration 112,113 .…”
Section: The Treatment Prospect Of Tgf-b Signaling In Ivd Degenerationmentioning
confidence: 99%